Clinical Scorecard: ECP 2026: Combined Approach Predicts Metastasis in Prostate Cancer

At a Glance

Key Highlights

• Study investigates molecular information to predict lymph node metastasis.
• Utilizes spatial transcriptomics to analyze gene activity in tumor regions.
• Machine learning models trained to recognize patterns linked to metastasis.
• Study cohort included 51 prostate cancer patients.
• Findings suggest potential for reducing unnecessary lymph node testing.

Guideline-Based Recommendations

Diagnosis

• Consider molecular profiling for better prediction of lymph node involvement.

Management

• Use machine learning models to identify patients at higher risk of metastasis.

Monitoring & Follow-up

• Further validation of findings needed before clinical application.

Risks

• Current methods may lead to unnecessary lymph node removal in some patients.

Patient & Prescribing Data

Patients with prostate cancer undergoing pelvic lymph node assessment.

Molecular information may guide surgical decision-making.

Clinical Best Practices

• Incorporate spatial transcriptomics in research for prostate cancer metastasis.
• Explore combination of molecular and morphological data for patient stratification.

Related Resources & Content

• ECP 2026 Presentation by Gabriel Wasinger